EcoDrugPlus

Secretin Receptor

Ensembl ID : ENSOCUG00000007710
Gene Symbol: SCTR
2 Cross references
130 Possible Orthologues:

Selectin E

Ensembl ID : ENSOCUG00000017438
Gene Symbol: SELE
2 Cross references
197 Possible Orthologues:

Selectin L

Ensembl ID : ENSOCUG00000017432
Gene Symbol: SELL
3 Cross references
86 Possible Orthologues:

Selectin P

Ensembl ID : ENSOCUG00000016477
Gene Symbol: SELP
4 Cross references
120 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSOCUG00000002891
Gene Symbol: SERPINC1
3 Cross references
199 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSOCUG00000000364
Gene Symbol: SIGMAR1
3 Cross references
204 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSOCUG00000009919
Gene Symbol: SIRT1
3 Cross references
155 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSOCUG00000013176
Gene Symbol: SMO
2 Cross references
204 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Alpha

Ensembl ID : ENSOCUG00000010152
Gene Symbol: SCNN1A
2 Cross references
153 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Beta

Ensembl ID : ENSOCUG00000008401
Gene Symbol: SCNN1B
2 Cross references
151 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Gamma

Ensembl ID : ENSOCUG00000017394
Gene Symbol: SCNN1G
3 Cross references
155 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 1

Ensembl ID : ENSOCUG00000007266
Gene Symbol: SCN1A
3 Cross references
139 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).